Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn M Millar

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|July 11, 2012
Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement productsCarolyn M Millar, Mike Makris
Clinical Medicine (London, England)|June 3, 2017
Drug therapy in anticoagulation: which drug for which patient?Carolyn M Millar, Mike A Laffan
Blood Reviews|March 2, 2006
Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand diseaseCarolyn M Millar, Simon A Brown
Clinical Medicine (London, England)|August 3, 2017
Corrigendum: Drug therapy in anticoagulation: which drug for which patient?Carolyn M Millar, Mike A Laffan
Blood|May 4, 2013
Blocking direct inhibitor bleedingCarolyn M Millar, David A Lane
British Journal of Haematology|June 13, 2002
Diabetes mellitus diagnosed following request for haemoglobin electrophoresisCarolyn M Millar, Lorraine Phelan, Barbara J Bain
Plos One|November 30, 2017
A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET constructChristopher J Lynch, Adam D Cawte, Carolyn M Millar, et al.
Blood Reviews|May 24, 2021
Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiencyFlora Peyvandi, Guenter Auerswald, Steven K Austin, et al.
Blood Reviews|October 9, 2022
A need to increase von Willebrand disease awareness: vwdtest.com - A global initiative to help address this gapFernando F Corrales-Medina, Augusto B Federici, Alok Srivastava, et al.
British Journal of Haematology|August 13, 2014
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in HaematologyMike A Laffan, Will Lester, James S O'Donnell, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|July 11, 2012
Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement productsCarolyn M Millar, Mike Makris
Clinical Medicine (London, England)|June 3, 2017
Drug therapy in anticoagulation: which drug for which patient?Carolyn M Millar, Mike A Laffan
Blood Reviews|March 2, 2006
Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand diseaseCarolyn M Millar, Simon A Brown
Clinical Medicine (London, England)|August 3, 2017
Corrigendum: Drug therapy in anticoagulation: which drug for which patient?Carolyn M Millar, Mike A Laffan
Blood|May 4, 2013
Blocking direct inhibitor bleedingCarolyn M Millar, David A Lane
British Journal of Haematology|June 13, 2002
Diabetes mellitus diagnosed following request for haemoglobin electrophoresisCarolyn M Millar, Lorraine Phelan, Barbara J Bain
Plos One|November 30, 2017
A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET constructChristopher J Lynch, Adam D Cawte, Carolyn M Millar, et al.
Blood Reviews|May 24, 2021
Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiencyFlora Peyvandi, Guenter Auerswald, Steven K Austin, et al.
Blood Reviews|October 9, 2022
A need to increase von Willebrand disease awareness: vwdtest.com - A global initiative to help address this gapFernando F Corrales-Medina, Augusto B Federici, Alok Srivastava, et al.
British Journal of Haematology|August 13, 2014
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in HaematologyMike A Laffan, Will Lester, James S O'Donnell, et al.
Pageof 3